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Intervertebral disc degeneration (IDD) causes chronic back
pain and is linked to production of proinflammatory molecules
by nucleus pulposus (NP) and other disc cells. Activation
of tonicity-responsive enhancer-binding protein (TonEBP)/
NFAT5 by non-osmotic stimuli, including proinflammatory
molecules, occurs in cells involved in immune response. How-
ever, whether inflammatory stimuli activate TonEBP inNP cells
and whether TonEBP controls inflammation during IDD is
unknown. We show that TNF-, but not IL-1 or LPS, pro-
moted nuclear enrichment of TonEBP protein. However, TNF-
-mediated activation of TonEBP did not cause induction of
osmoregulatory genes. RNA sequencing showed that 8.5% of
TNF- transcriptional responses were TonEBP-dependent and
identified genes regulated by both TNF- and TonEBP. These
genes were over-enriched in pathways and diseases related to
inflammatory response and inhibition of matrix metallopro-
teases. Based on RNA-sequencing results, we further investi-
gated regulation of novel TonEBP targets CXCL1, CXCL2, and
CXCL3. TonEBP acted synergistically with TNF- and LPS to
induce CXCL1-proximal promoter activity. Interestingly, this
regulation required a highly conserved NF-B-binding site but
not a predicted TonE, suggesting cross-talk between these two
members of the Rel family. Finally, analysis of human NP tissue
showed that TonEBP expression correlated with canonical
osmoregulatory targets TauT/SLC6A6, SMIT/SLC5A3, and
AR/AKR1B1, supporting in vitro findings that the inflammatory
milieu during IDD does not interfere with TonEBP osmoregu-
lation. In summary, whereas TonEBP participates in the proin-
flammatory response to TNF-, therapeutic strategies targeting
this transcription factor for treatment of disc diseasemust spare
osmoprotective, prosurvival, and matrix homeostatic activities.
The transcription factor TonEBP,4 or NFAT5, is essential for
the coordinated response of mammalian cells to osmotic stim-
uli, which includes the accumulation of non-ionic organic
osmolytes and heat-shock proteins that prevent damage to cel-
lular proteins and nucleic acids (1). Nucleus pulposus (NP) cells
of the healthy intervertebral disc are subject to a hyperosmotic
environment, which fluctuates with daily postural changes (2,
3). Previously, we have shown that TonEBP regulates survival of
NP cells and maintains transcription of genes necessary for
matrix homeostasis under hyperosmotic conditions (4–6).
However, the regulation of TonEBP under inflammatory con-
ditions and its role in disc degeneration remain unexplored.
Intervertebral disc degeneration (IDD) is an important risk
factor for chronic low back and neck pain (7), which is a ubiq-
uitous and costly pathological condition (8) that contributes
heavily to disability in the United States and worldwide (9–11).
During IDD, changes in both cellular behavior and extracellular
matrix makeup ultimately compromise biomechanical func-
tion of the disc. NP and other disc cells produce cytokines,
including tumor necrosis factor- (TNF-)/TNF and IL-1,
which contribute to an inflammatory environment through
NF-B- and MAPK-signaling pathways and promote produc-
tion of matrix-degradingMMP and ADAMTS family members
(12–16). Catabolism of the NP extracellular matrix limits its
water-binding capacity, eventually leading to a stiffer matrix,
decreased disc height, and altered mechanical loading (17, 18).
Moreover, excessivemechanical loading (19) andmatrix break-
down products (20) can also activate toll-like receptors (TLRs)
expressed on NP cells.
Interestingly, independent of hyperosmolarity, TonEBP/
NFAT5 expression is induced in response to inflammatory
stimuli, including IFN- and IL-4 (21), in immune cells. Like-
wise, TonEBP can be induced by TLR activation through LPS
(21–23), Escherichia coli (22), or Mycobacterium tuberculosis
(24). Following LPS stimulation, TonEBP is required for anti-
microbial response through regulation of NOS2 and other
target genes (23). Moreover, in fibroblast-like synoviocytes
derived from rheumatoid arthritis patients, TNF- and IL-1
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induce levels and nuclear localization of TonEBP. In these cells,
TonEBP controls cell survival, proliferation, migration, and
angiogenesis (25). However, whether such changes in TonEBP
activation occur during disc degeneration is not known.
In this study, we investigatedwhetherTonEBP is activated by
proinflammatory stimuli in NP cells and its role in this context.
TonEBP activity, but not expression, was modulated by proin-
flammatory stimuli in NP cells. Importantly, TNF--induced
TonEBP selectively controls inflammatory gene expression
without affecting its canonical osmoregulatory targets. Our
results clearly suggest that TonEBP is critical for TNF--medi-
ated expression of several molecules thought to play a key role
during disc degeneration.
Results
TNF- promotes TonEBP nuclear localizationwithout
affecting transcript levels
Previous studies in immune cells and rheumatoid arthritis-
fibroblast-like synoviocytes have shown activation of TonEBP/
NFAT5 by various inflammatory stimuli, including TNF-.
Therefore, we investigated whether TNF-, IL-1, and LPS
promote TonEBP expression in NP cells. Interestingly, none of
these proinflammatory stimuli affected TonEBP mRNA levels,
although induction was seen with hyperosmolarity (Fig. 1A).
We evaluated levels of total TonEBP protein following 4–24 h
of stimulation with TNF-, IL-1, and LPS and found no sig-
nificant differences with stimulation (Fig. 1, B and C). Surpris-
ingly, only treatment with TNF- significantly increased the
nuclear pool of TonEBP protein (Fig. 1, D and E), whereas nei-
ther IL-1 (Fig. 1, F and G) nor LPS (Fig. 1, H and I) treatment
had any effect onnuclear enrichment ofTonEBP.This response
is different from what has been reported for immune cells and
fibroblast-like synoviocytes (21, 25). A similar enrichment in
nuclear TonEBP was observed with immunofluorescent stain-
ing (Fig. 1J).
TonEBP activation under inflammatory conditions fails to
induce transcription of osmoregulatory target genes
Nuclear accumulation of TonEBP is a shared feature of
response to hyperosmolarity and TNF- and an important
indicator of TonEBP activation. We wanted to investigate
whether TNF-, and inflammatory stimuli such as IL-1 and
LPS that do not affect nuclear translocation, can modulate the
phosphorylation status of the TonEBP transactivation domain
(TAD). Activity of the TonEBP-TAD (amino acids 548–1531)
was assessed using a binaryGAL4 system, as depicted in Fig. 2A.
Interestingly, addition of TNF-, IL-1, or LPS had no effect on
Ton-TAD activity (Fig. 2B). As expected, treatment with NaCl
induced TonTAD activity. Interestingly, TAD induction by
NaCl was inhibited by co-treatment with TNF-, but not IL-1
or LPS (Fig. 2B). We then assessed the activity of the proximal
TauT promoter, which contains a highly conserved TonEBP-
binding site (TonE) shown to be active in NP cells (Fig. 2C) (4,
26). Similarly to TonEBP-TAD, TNF-, IL-1, and LPS did not
affect activity, whereas NaCl strongly induced promoter activ-
ity (Fig. 2D). Because TNF- promoted TonEBP nuclear trans-
location, we investigated whether mRNA levels of traditional
osmoregulatory TonEBP target genes TauT/SLC6A6, SMIT/
SLC5A3, and AR/AKR1B1 were affected by TNF- as well as
IL-1 and LPS. None of these target genes were significantly
induced by proinflammatory stimuli; again, levelswere elevated
by treatment with NaCl (Fig. 2, E–G). Finally, we investigated
whether co-treatment of TNF- along with NaCl would affect
inducibilty of osmoregulatory targets. TauT, SMIT, and AR
were all significantly induced by treatment with 24 h of NaCl
alone. Addition of TNF- along with NaCl did not impact
inducibilty of TauT, SMIT, or AR (Fig. 2H).
RNA sequencing reveals TonEBP as a critical regulator of NP
cell response to TNF-
Because our results suggested that TNF- and other inflam-
matory stimuli do not induce TonEBP targets concerned with
cellular osmosensing, we employed an -omics approach to
identify the unique transcriptional targets of TonEBP during
TNF- stimulation.We performed RNA sequencing on rat NP
cells that were transduced with either lentivirally-delivered
ShControl or ShTonEBP with or without TNF- treatment for
24 h. TonEBP controlled expression of 405 genes in untreated
cells and 371 genes under TNF- stimulation (Fig. 3A). Impor-
tantly, although some TonEBP targets were shared between
untreated and TNF--treated NP cells, a substantial number
were treatment-specific (Fig. 3B). Furthermore, RNA-seq iden-
tified 1339 genes that were differentially expressed between
basal andTNF--treated groups (Fig. 3C).We found that out of
all genes differentially regulated by TNF-, 50.6% were posi-
tively and 49.4% were negatively regulated. We then deter-
mined what proportion of the transcriptional output of TNF-
could be attributed to TonEBP in NP cells. Overall, out of all
genes modulated by TNF-, 8.5% were also regulated by
TonEBP (Fig. 3D). Of the genes positively regulated by TNF-,
12.1% (Fig. 3E) showed positive and 1.3% showed negative cor-
relation with TonEBP. Likewise, of genes negatively regulated
by TNF-, 0.3% were positively and 4.8% were negatively cor-
related with TonEBP (Fig. 3E). Because TNF- is closely linked
to enhanced matrix catabolism and inflammation during disc
degeneration, we decided to focus on genes that were positively
regulated by both TNF- and TonEBP and performed ingenu-
ity pathway analysis (IPA) on this subset of genes. Several
pathways important in the context of disc degeneration and
metabolism emerged, including inhibition of matrix metallo-
proteases, IL-17-related pathways, and HIF-1 signaling
(supplemental Table 1). Top diseases and disorders included
inflammatory response, connective tissue disorders, and skele-
tal and muscular disorders (supplemental Table 2). Networks
associated with this gene list included hematological system
development and function, inflammatory response, and tissue
morphology and cellularmovement, connective tissue develop-
ment and function, and tissue development (supplemental
Table 3). Log2 (-fold change) values from RNA-seq results for
select genes in these identified pathways is shown in Fig. 3F.
These genes were significantly different between indicated
experimental groups, as defined by adjusted p value 0.05.We
also validated some of the TonEBP targets shown in Fig. 3C
that were most closely linked to disc degeneration using
qRT-PCR and ELISA. As seen before, TonEBP and TauT
levels were unaffected by TNF- treatment but, expectedly,
TNF--activated TonEBP regulates inflammatory genes
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decreased with TonEBP silencing (Fig. 4A). Expression of
genes associated with matrix catabolism such as ADAMTS4,
ADAMTS5, andMMP3 were all decreased by TonEBP knock-
down in the presence of TNF- (Fig. 4B). In addition, we inves-
tigated howexpression of keyNPmatrixmolecules known to be
suppressed by TNF- were affected by TonEBP silencing. The
suppressive effect of TNF- on ACAN and COL2A1 was not
changed by TonEBP knockdown (Fig. 4C). This is likely due to
the fact that TonEBP has been shown to positively regulate
these genes in NP and chondroprogenitor cells (4, 27).
Additionally, we studied expression of several cytokines,
chemokines, and regulators of the inflammatory response in
TonEBP-silenced NP cells under TNF- stimulation. TNF-
induced mRNA levels of TNF, NOS2, PHD3, and TLR2, and
this induction was significantly decreased following TonEBP
knockdown (Fig. 5A). Similarly, we measured mRNA and pro-
tein levels of CCL2 and IL-6 in TonEBP-silenced cells. Both
genes were induced by TNF- treatment (Fig. 5B). The tran-
script and protein levels were significantly suppressed by
TonEBP knockdown following TNF- treatment (Fig. 5, B–D).
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Figure 1. TNF- promotes nuclear localization of TonEBPwithout affecting transcript levels. A, TonEBPmRNA levels were unaffected by treatment with
TNF-, IL-1, or LPS for 4–24 h; as expected, treatment with NaCl (110 mM) resulted in induction. B and C, levels of total cellular TonEBP did not change with
TNF- treatment for 4–24 h. D and E, nuclear and cytoplasmic fraction experiment clearly shows increased nuclear accumulation of TonEBP following TNF-
treatment for 24 h. No discernable depletion of TonEBP in cytoplasmic fraction was seen. Lamin and -tubulin loading controls showed relatively high purity
of fractions. F–I, treatmentwith IL-1 (FandG) andLPS (Hand I) for 4–24hdidnot affect theamountof nuclear TonEBPprotein. J, immunofluorescentdetection
of TonEBP in NP cells following 24 h of treatment with NaCl or TNF-. Inset shows highmagnification image of cells. Scale bar, 100m. Quantitative measure-
ments represent mean S.E. of3 biological replicates. *, p 0.05; **, p 0.01. ns, not statistically significant. Neg. CTR, negative control.
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TonEBP promotes TNF--mediated induction of CXCL1, CXCL2,
and CXCL3
Our RNA-seq results suggested that TonEBP regulated
expression of CXCL2 and CXCL3. Therefore, we further inves-
tigated regulation of CXCL family members by TonEBP in NP
cells. Treatment with TNF- induced mRNA levels of CXCL1,
CXCL2, and CXCL3, which were significantly decreased in
TonEBP-knockdown NP cells (Fig. 5E). To evaluate levels of
CXCL proteins, we collected conditioned media from control
and TonEBP-knockdown cells and performed immunoblots.
We found that TNF--mediated induction of CINC1/CXCL1,
CINC3/CXCL2, and CINC2/CXCL3 protein was also inhibited
in TonEBP-silenced cells (Fig. 5F).
TonEBP controls activity of the CXCL1 promoter via a highly
conserved NF-B-binding site
To investigate whether TonEBP acts directly on the CXCL1
promoter, we studied the proximal (1.5 kb) promoter region of
the ratCXCL1 gene. UsingMatInspector software, we searched
for potential TonE’s in the promoter, finding only a single site
Figure 2. TonEBP activation under inflammatory conditions fails to induce transcription of its canonical osmoregulatory target genes. A, schematic
depicting binary TonTAD-GAL4 systemused tomeasure TonEBP-TAD activity. B, activity of TonEBP-TADwas unaffected by treatmentwith TNF-, IL-1, or LPS
alone, but it was induced by NaCl. Co-treatment with TNF- and NaCl dampened the TAD activation by NaCl alone. C, diagram showing taurine transporter
(TauT) luciferase reporter, which contains an active, highly conserved TonEBP-binding site, TonE.D, although treatmentwith NaCl induced activity of the TauT
promoter, treatment with TNF-, IL-1, or LPS had no effect. E–G, TauT (E), SMIT (F), and AR (G) mRNA levels did not significantly increase with TNF-, IL-1, or
LPS treatment for 4–24 h, whereas 8 h of NaCl treatment resulted in induction. H, co-treatment of TNF- along with NaCl did not affect NaCl-mediated
induction of TauT, SMIT, or AR. Quantitative measurements represent mean S.E. of3 biological replicates and, for transfection experiments, 3 technical
replicates per biological replicate. *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001; ns, not statistically significant.
TNF--activated TonEBP regulates inflammatory genes
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using a prediction score cutoff of 0.8, in addition to five NF-B
sites predicted earlier (28). To test the effects of various stimuli
on the CXCL1 promoter, we measured activity of a wild-type
promoter-luciferase reporter construct (Fig. 6A). Similarly, we
measured activities of the construct with the predicted TonE
mutation and a construct with the mutation in the most active
NF-B site, which was experimentally validated in a previous
study (four other NF-B sites are wild type) (28). To test
whether TonEBP controls activity of the CXCL1 promoter
and its mode of regulation, we overexpressed either wild-type
(TonEBP) or dominant-negative (DN-TonEBP) TonEBP and
measured activities of wild-type as well as mutant promoters.
Surprisingly, although TonEBP induced activity of both wild-
type and TonE-mutant CXCL1 promoters, it had no effect on
theNF-B-mutant promoter (Fig. 6B).Moreover, DN-TonEBP
had no effect on any of the promoters under basal conditions
(Fig. 6B). We then explored whether modulation of TonEBP
would impact the responsiveness of these promoters to various
inflammatory stimuli. We found that overexpression of
TonEBP enhanced the inductive effect of TNF- on the wild-
type and TonE-mutant promoters. Although TNF- increased
activity of the NF-B-mutant, TonEBP failed to further induce
this activity (Fig. 6C). In contrast, TonEBP overexpression had
no synergistic effect on IL1--mediated induction in activity of
wild-type andTonE-mutant promoters. IL-1did not affect the
activity of the NF-B mutant, and there was no modulation
Figure3.RNAsequencing revealsTonEBPasan important regulatorofNPcell response toTNF-.NPcellswere transducedwitheither ShControl or ShTonEBP
and cultured with or without TNF- for 24 h, and RNA sequencing was performed. A, heat map depicting genes differentially expressed between shControl and
shTonEBPunder either basal or TNF--stimulated (24-h TNF-) conditions.B,VenndiagramshowingoverlapbetweenTonEBP-dependent genes in untreated versus
TNF--treated cells. C, heat map depicting genes differentially expressed between control and TNF- treatment groups. D, volcano plot depicting expression of
transcripts that are differentially expressed between control and TNF- treatment groups and controlled by TonEBP under TNF- treatment. E, Venn diagrams
showing overlap between genes positively or negatively regulated by TNF- and also regulated by TonEBP. F, log2(fold change) values for inflammation-related
transcripts thatweredifferentiallyexpressedbetweencontrolandTonEBPknockdownunderTNF- treatment;genesshownwerestatisticallysignificantbetweenthe
indicated experimental groups, as defined by adjusted p value0.05. Quantitativemeasurements representmean S.E. of3 biological replicates.
TNF--activated TonEBP regulates inflammatory genes
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by co-expression of TonEBP. However, DN-TonEBP blocked
IL-1-mediated induction in wild-type and TonE-mutant pro-
moter activity. Again, therewas no effect ofDN-TonEBP on the
NF-B-mutant promoter (Fig. 6D). In contrast to TNF- and
IL-1 treatment, LPS alone did not induce activity of any of the
promoters. Interestingly, induction of wild-type promoter
activity was seen when LPS was combined with TonEBP over-
expression and to a lower extent with TonE mutation; again,
there was no effect on the NF-B-mutant (Fig. 6E). Finally, we
added a small dose of p65 plasmid such that further induction
of the promoter could be achieved, and we evaluated the ability
of TonEBP to modulate its effects on the CXCL1 promoter.
Although there was a trend of increased activity of all three
promoters (wild-type, TonE-, and NF-B-mutant) in presence
of p65, it did not reach statistical significance. However,
TonEBP co-expression was able to enhance activity of all pro-
moters, including the NF-B-mutant (Fig. 6F). We further
examined the ability of TonEBP to act synergistically with
NF-B signaling by measuring activity of an NF-B reporter in
response to TNF- treatment along with TonEBP. Although
TNF- alone induced NF-B reporter activity, expression of
TonEBP further enhanced this effect (Fig. 6G). To test whether
cross-talk between osmotic response and inflammatory path-
ways impacted CXCL1 response to TNF-, we measured
mRNA expression following treatment with NaCl alone,
TNF- alone, or NaCl with TNF-. We found that CXCL1
expression was unaffected by NaCl and was induced by TNF-.
Furthermore, co-treatment with NaCl and TNF- did not
impact inducibilty by TNF- (Fig. 6H).
TonEBP controls the CXCL2 promoter under specific stimuli
Because CXCL1 and CXLC2 showed similar patterns of
expression in response to TNF- stimulation and TonEBP
modulation, we investigated regulation of theCXCL2 promoter
as well. MatInspector analysis predicted two TonEs in the
1.5-kb proximal promoter fragment (Fig. 7A) along with two
previously predicted NF-B sites, one of which is highly con-
served (28). Interestingly, Multiz alignment of the rat and
human genomes showed no evolutionary conservation of these
TonEs, suggesting relatively low likelihood of physiological
importance.We therefore chose to study only thewild-type and
NF-B-mutant (mutation of more highly conserved NF-B
site) promoters in these studies. Wild-type CXCL2 promoter
showed induction in activity by TNF- (Fig. 7B), IL-1 (Fig.
7C), and LPS (Fig. 7D). The induction by IL-1 and LPSwas lost
when the NF-B site was mutated, whereas TNF--mediated
induction was decreased by mutation, suggesting that this site
was important for mediating response to inflammatory stimuli.
Interestingly, althoughTonEBPoverexpression resulted in syn-
ergistic activation of wild-type promoter only in the presence of
LPS stimulation, DN-TonEBP had no effect on promoter activ-
ity in the presence of any inflammatory stimuli (Fig. 7, B–D).
We then tested the effect of a small dose of p65 along with
TonEBPmodulation on the CXCL2 promoter activity. Surpris-
ingly, both the wild-type and NF-B-mutant promoters were
induced by p65. Although there was a trend of TonEBP further
inducing wild-type reporter activity, this was significant in the
case of the NF-B-mutant reporter (Fig. 7E), underscoring the
Figure 5. TonEBP controls TNF--mediated induction of key cytokines,
chemokines, and inflammatorymolecules in NP cells. A, TNF- treatment
induced expression of TNF, NOS2, PHD3, and TLR2mRNAs, which was signifi-
cantly inhibited by TonEBP knockdown. B and C, expression level of CCL2 and
IL-6 mRNA (B) and CCL2 protein (C) were induced by TNF- treatment; this
induction was blocked by TonEBP knockdown. D, IL-6 protein levels were
decreased by TonEBP knockdown under TNF- treatment condition. E and F,
CXCL1/CINC1, CXCL2/CINC3, and CXCL3/CINC2mRNA (E) and protein (F) lev-
elswere inducedby TNF- in cell transducedwith ShControl and significantly
decreased by TonEBP knockdown. Quantitative measurements represent
mean S.E. of3biological replicates. *, p 0.05; **, p 0.01; ***, p 0.001;
****, p 0.0001. ns, not statistically significant.
Figure 4. TonEBP regulates TNF--dependent expression of select
genes linked to matrix catabolism. A, qRT-PCR confirmation of TonEBP
knockdown. TonEBP and TauT mRNA levels were unaffected by TNF-
treatment in ShControl-transduced cells but decreased in cells trans-
duced with ShTonEBP. B, TonEBP regulated transcript levels of matrix cat-
abolic enzymes ADAMTS4, ADAMTS5, andMMP3 under TNF- treatment. C,
TNF- treatment significantly decreases transcript levels of ACAN and
COL2A1 in ShControl-transduced cells. Levels were unaffected by knock-
down of TonEBP. Quantitativemeasurements representmean S.E. of3
biological replicates. *, p  0.05; **, p  0.01, ****, p  0.0001. ns, not
statistically significant.
TNF--activated TonEBP regulates inflammatory genes
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possible contribution of TonEBP in enhancing activity of p65.
DN-TonEBP did not block p65-mediated induction of either
thewild-type ormutant reporter (Fig. 7E). Finally, wemeasured
CXCL2 response to TNF- in the presence or absence of NaCl.
Similar toCXCL1, mRNA expression ofCXCL2was unaffected
by NaCl, induced by TNF- treatment, and this induction was
not affected by co-treatment with NaCl (Fig. 7F). Similarly,
hyperosmolarity did not affect TNF--dependent expression of
PHD3 or TLR2; induction ofMMP3 was decreased in the pres-
ence of NaCl (supplemental Fig. 1, A–C).
TonEBP expression is maintained during human disc
degeneration and regulates osmoprotective target genes
To investigate changes inTonEBP during human disc degen-
eration, we measured its expression in human tissue samples.
The percentage of TonEBP-immunopositive cells was un-
Figure 6. TonEBP controls the activity of the CXCL1 promoter via a highly conserved NF-B-binding site. A, diagram showing predicted TonEBP- and
NF-B-binding sites in the ratCXCL1proximal promoter spanning1.5 kb upstreamof the transcription start site. Predicted TonE is depicted by gray circle and
NF-B-binding sitesbyopen squares. NF-B-mutant reporter containsmutation inbinding site 2 (star),whichhashigh species conservationandactivity inother
cell types. B, under basal conditions, TonEBP increased activities ofWT and TonE-mutant promoters, whereas NF-B-mutant was unaffected. C,WT, TonE-, and
NF-B-mutant reporters were all induced by TNF- treatment. During TNF- treatment, addition of TonEBP further induced activity of WT and TonE-mutant
reporters only. D,WT and TonE-mutant reporters, but not NF-B-mutant, were induced by IL-1 treatment. During IL-1 stimulation, addition of TonEBP did
not affect inducibility of any of the reporters, whereas DN-TonEBP blocked induction ofWT and TonE-mutant reporters. E, none of the reporters responded to
LPS treatment alone. Addition of TonEBP during LPS treatment induced activity in WT and TonE-mutant reporters only. F, addition of small amount (15 ng) of
p65 plasmid resulted in a trend of increased activity in all reporters, which was further enhanced by addition of TonEBP. G, expression of TonEBP further
increased TNF--dependent induction of NF-B reporter activity.H, treatmentwith TNF-, but not NaCl, inducedmRNA expression of CXCL1. TNF--mediated
induction was unaffected by co-treatment with NaCl. Quantitative measurements represent mean  S.E. of 3 biological replicates and, for transfection
experiments, 3 technical replicates per biological replicate. *, p 0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001. ns, not statistically significant.
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changed between non-degenerated (grade 4) and degener-
ated (grade 4) samples (Fig. 8, A and B). Finally, we investi-
gated the relationship between expression levels of TonEBP
and its osmoregulatory targets in human tissues. Because of
limited RNA quantity, we found that HPRT1 expression was
not detectable in all samples. To find a suitable housekeeping
gene whose expression level could be readily detected in all
samples, we performed correlation analysis ofHPRT1, 18S, and
GAPDH expression in all human samples. Levels of 18S and
GAPDH correlated well in all samples, and HPRT1 correlated
with each of these in samples where HPRT1 was detectable
(supplemental Fig. 2, A–C). We found strong correlations
between TonEBP and TauT, SMIT, and AR in these samples
(Fig. 8, C–E).
Discussion
Previouswork has demonstrated that TonEBP is required for
survival and function of NP cells in the osmotically challenging
environment of the intervertebral disc (4–6). In the healthy
NP, abundant proteoglycans and collagen afford the tissue high
osmotic pressure (29). Furthermore, osmolarity of the NP is
dynamic due to diurnal posture changes; water is effluxed with
Figure 7. TonEBP controls the CXCL2 promoter only under certain stimulatory conditions. A, diagram showing predicted TonEBP- and NF-B-binding
sites in the rat CXCL2 proximal promoter spanning1.5 kb upstream of the transcription start site. TonEs are depicted by gray circles and NF-B-binding sites
byopen squares. NF-B-mutant reporter containsmutation inbinding site 2 (star),whichhashigh species conservationandactivity inother cell types.B,WTand
NF-B-mutant (to a smaller extent) reporters were induced by TNF-, whereas further addition of TonEBP or DN-TonEBP had no effect. C, WT reporter was
inducedby IL-1, and further addition TonEBP orDN-TonEBP had no effect on reporter activity.D, LPS inducedWT reporter activity, with further enhancement
by addition of TonEBP. E, addition of small amount of p65 plasmid induced activity of both reporters. Addition of TonEBP along with p65 resulted in further
induction of the NF-B-mutant; there was a small trend of increase for the WT promoter. F, treatment with TNF-, but not NaCl, increased CXCL2 mRNA
expression. TNF--dependent induction was unaffected by co-treatment with NaCl. Quantitative measurements represent mean  S.E. of 3 biological
replicates and, for transfection experiments, 3 technical replicates per biological replicate. *, p  0.05; **, p  0.01; ***, p  0.001; ****, p  0.0001. ns, not
statistically significant.
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loading during the day and imbibed when loading is relieved at
night (30–32). We have shown that, in healthy NP cells,
TonEBP regulates genes involved in cell survival, matrix home-
ostasis, and water transport in response to hyperosmolarity
(4–6, 33). However, the role of TonEBP in a degenerative disc,
characterized by tissue inflammation and enhanced matrix
catabolism, is unknown (16, 34). Importantly, although osmotic
loads in the healthyNP reach 450–550mosM/liter, this number
declines in degenerating discs (35). Another classic feature of
disc degeneration is the presence of inflammatory cytokines,
including TNF- (36) and IL-1 (37, 38), which promote
matrix degradation (13, 14, 39, 40), chemokine secretion (41,
42), cellular senescence (43), and autophagy (44). The aim of
this study was to determine the activity and role of TonEBP
under inflammatory conditions that define the degenerative
intervertebral disc milieu.
In NP cells, TNF- treatment promoted nuclear localization
of TonEBPwithout affectingmRNAor total protein levels. This
is in contrast to osmotic activation of TonEBP,which includes a
rapid mRNA induction, increase in total protein abundance,
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Figure 8. TonEBP expression is correlated with levels of osmoprotective genes in human NP samples. A, immunohistochemical staining of TonEBP in
non-degenerated (grades4) and degenerated (grades4) human NP samples. Isotype IgG was used as negative control for staining. B, percentage of cells
immunopositive for TonEBPwas not significantly different betweennon-degenerated anddegenerated tissue samples.C–E, correlationbetweenmRNA levels
of TonEBP and osmoregulatory target genes TauT (p  0.0044) (C), SMIT (p  0.03) (D), and AR (p  0.0554) (E) was seen in all tissue samples analyzed. F,
schematic of proposed regulation of TonEBP by TNF- and downstream transcriptional responses. Activation by either TNF- or NaCl induces nuclear
abundance of TonEBP, but only NaCl induces TonEBP transcript levels. Upon stimulation with TNF-, TonEBP participates in cross-talk with NF-B family
members topromote transcriptionof proinflammatory genes.A, scale bar for40 images (left) is 100m, and scale bar for100 images (right) is 50m.ns,not
statistically significant.
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and nuclear translocation (45–47). Moreover, our result is in
partial agreement with a previous report showing that TNF-
and IL-1 (25) can enhance both the total and nuclear fraction
of TonEBP in other cell types. Further experiments highlighted
differences between TonEBP activation by osmotic and inflam-
matory stimuli. Increased activity of TonEBP-TAD is a critical
feature of osmotic stimulation of TonEBP activity (48). In con-
trast, treatment with TNF-, IL-1, or LPS did not increase
TAD reporter activity. Importantly, genes considered to be
faithful TonEBP targets were not induced by any of these
inflammatory mediators in NP cells, despite evidence of
increased nuclear localization of TonEBP by TNF-. These
results suggest that the mechanism of TonEBP activation dif-
fers substantially between osmotic and inflammatory condi-
tions. It is plausible that TonEBP target selectivity may depend
on TAD activation status, as has been demonstrated for other
transcription factors expressed in the NP niche (49). Interest-
ingly, previous studies suggest that cross-talk exists between
osmotic and inflammatory response pathways. In RPE cells,
high salt enhances IL-6 and CCL2 production in response to
LPS (50). However, in human neutrophils and mononuclear
cells, high salt reduces production of proinflammatory cyto-
kines in response to LPS treatment (51). A 2013 study by Kim et
al. (22) showed that both high salt and LPS induce TonEBP in
macrophages via different sources of reactive oxygen species. In
these cells, high salt and LPS had reciprocal effects on TonEBP
target genes; pretreatment with LPS dampened the osmopro-
tective response to high salt, and pretreatment with NaCl
decreased LPS-mediated induction of IL-6 (22). In contrast, our
studies show that, whereas TNF- influences TonEBP-TAD
activation status, the effect on hyperosmolarity-dependent
induction of TauT, SMIT, and AR, canonical osmoregulatory
TonEBP targets, is minimal. Thus, the outcome of cross-talk
between inflammatory and osmotic stimuli appears to be cell
type-specific.
Despite increased nuclear TonEBP, there was lack of induc-
tion of canonical osmoregulatory TonEBP targets by TNF-,
which prompted us to perform RNA-seq to identify novel
TonEBP targets in this context. Results of these experiments
clearly showed that TonEBP governs pathways and functional
categories related to inflammatory response, matrix degrada-
tion, tissue fibrosis, and interleukin signaling during TNF-
treatment of NP cells.We found that TonEBP controls TNF--
dependent expression of ADAMTS4, ADAMTS5, and MMP3,
matrix-degrading enzymes implicated in disc degeneration
(12–14). Likewise, TonEBP controlled expression of PHD3, a
recently identified regulator ofNF-B signaling inNP cells (52).
In addition, TonEBP modulated levels of TNF, NOS2, TLR2,
CCL2, and IL-6, molecules usually linked to tissue inflamma-
tion. These results are in agreement with previous studies in
macrophages that showed TonEBP plays a role in TLR-trig-
gered induction of NOS2, IL6, TNF, and CCL2 (23). Interest-
ingly, we and others have shown that levels ofCCL2, IL6,NOS2,
and TNF are also transiently induced by hyperosmolarity in a
TonEBP-dependent manner (6, 53, 54). Importantly, RNA-seq
data revealed that only about 8.5% of the TNF--mediated
response in NP cells is TonEBP-dependent. Concerningmatrix
homeostasis, suppression ofACAN andCOL2A1 byTNF-was
not TonEBP-dependent. On the contrary, both of these critical
matrix genes have been described as transcriptional targets of
TonEBP under basal and hyperosmolar conditions (4, 27, 56).
These results suggest that modulation of TonEBP activity may
not fully reverse transcriptional changesmediated by TNF- in
NP cells.
In addition to these catabolic and inflammatory genes, our
results show for the first time that TonEBP controlled TNF--
dependent expression of CXCL1/CINC1, CXCL2/CINC3, and
CXCL3/CINC2. Studies have detected expression of CXCL1,
CXCL2, and CXCL3 in both healthy and degenerative NP tis-
sues with some changes in disc infiltrated by immune cells (38).
Underscoring the importance of CXCL1/CINC1, administra-
tion of anti-CINC1 antibody significantly decreased pain in a
murine model of disc herniation, as measured by mechanical
and thermal hyperalgesia (57). Traditionally considered che-
moattractants for macrophages and neutrophils, the function
and molecular regulation of CXCL1, CXCL2, and CXCL3
expression in the intact, immune privileged disc is unknown.
Interestingly, NP cells express CXCR2, a receptor for both
CINC1 and CINC3, and receptor expression increases with
grade of degeneration (58), suggesting that these chemokines
may act on NP cells in an autocrine or paracrine manner and
play a role in normal tissue physiology. However, following
structural damage to the NP, such as herniation, we hypothe-
size that high levels of these CXCL familymembers would drive
macrophage and neutrophil migration. Our studies of the
CXCL1 promoter revealed an unexpected mode of regulation;
the effects of TonEBP required the presence of a highly active
NF-B-binding site (641/632) but not the predicted TonE
(124/127). This result raised the question of whether
TonEBP might interact with p65 at this NF-B-binding site.
Indeed, Roth et al. (59) have shown that TonEBP interacts with
NF-B-binding sites of TNF, CCL2, and IB in response to
hyperosmolarity, presumably as part of a NF-B–TonEBP
complex. In macrophages, TonEBP plays a role in activation of
LPS-induced NF-B activity by recruiting the transcriptional
co-activator p300 to the NF-B enhanceosome (60). Likewise,
we have previously shown that NF-B activity is required for
hyperosmotic induction of a subset of TonEBP targets and that
NF-B activation by hyperosmolarity depends on functional
TonEBP (6). However, these studies also showed that TonEBP
was not immunoprecipitated with p65 under conditions of
either hypertonicity or TNF- stimulation, suggesting either a
very transient nature of interaction between these proteins or
lack thereof (6). The synergistic action of TonEBP and TNF-
on the CXCL1 promoter and NF-B prototypic reporter sup-
ports the possibility of a transient interaction between TonEBP
and p65 and/or other NF-B subunits, including p50. Interest-
ingly, the ability of TonEBP to regulate the CXCL1 and CXCL2
promoters varied between inflammatory mediators, suggesting
stimulus-specific mechanisms of regulation. Importantly, our
results suggest that the highly conserved NF-B-binding site in
the CXCL2 promoter is important in mediating response to
inflammatory stimuli and that the less conserved TonEs may
not mediate the observed effects of TonEBP on TNF--medi-
ated CXCL2 transcription. Moreover, results of p65 and
TonEBP co-transfections show that TonEBP may enhance
TNF--activated TonEBP regulates inflammatory genes
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activity of p65 even on a less conserved NF-B-binding site,
such as thewild-typeNF-B site 1 in theCXCL2NF-B-mutant
promoter. Similar to experiments that investigated the effect of
TNF- on osmoregulatory genes, we did not observe modula-
tion of inflammatory TonEBP targets CXCL1 and CXCL2 by
hyperosmolarity. There was also no effect of co-treatment with
TNF- and hyperosmolarity on TNF--mediated induction of
CXCL1 and CXCL2 expression. These results suggest that,
unlike in macrophages, in NP cells hyperosmolarity does not
inhibit TonEBP action on these inflammatory target genes.
We evaluated TonEBP levels in human samples from healthy
and degenerative discs. Although the number of TonEBP-pos-
itive NP cells was unaffected by degeneration, we did not quan-
titatively measure changes in nuclear protein level on a per cell
basis because of limited amount of tissue sample. Importantly,
however, strong correlation between expression levels of
TonEBP and its canonical osmoregulatory targetsTauT, SMIT,
and AR supports in vitro findings and reflects the fact that the
inflammatory milieu of disc degeneration does not interfere
with the ability of TonEBP to act on its osmoregulatory targets.
Together, our results show that TNF- activates TonEBP by
promoting its nuclear localization to regulate expression of a
subset of the TNF--induced inflammatory response in NP
cells (schematic, Fig. 8F). These results invite the possibility
that targeted TonEBP inhibition might be a novel therapeutic
strategy to treat disc degeneration. Indeed, TonEBP heterozy-
gosity partially protectsmice fromcomplete Freund’s adjuvant-
induced arthritis (61). However, it is important to consider the
pro-survival, matrix homeostatic, and other physiological
activities of TonEBP in theNPwhen developing such a therapy.
Experimental procedures
Isolation and treatment of NP cells
Rat NP cells were isolated using a method described previ-
ously (62). Collection of animal tissues for cell isolation was
approved by the IACUC at Thomas Jefferson University. Cells
were maintained in DMEM with 10% FBS and antibiotics. For
hypertonic culture, 110 mM NaCl was added to medium; for
TNF- treatment, 50 ng/ml was added to medium; for IL-1
treatment, 10 ng/mlwas added tomedium; for LPS treatment, 2
ng/ml was added to medium.
Human tissue collection and grading
Human lumbar intervertebral disc (IVD) tissue was obtained
either at surgery or post-mortem (PM) examination with
informed consent of the patient or relatives (Sheffield Research
Ethics Committee no. 09/H1308/70). Four PM IVDs were
recovered from three donors. They consisted of intact IVDs
within the complete motion segment from which the IVDs
were removed. Sixty surgical IVD tissue samples were obtained
from patients undergoing microdiscectomy procedures for the
treatment of low back pain and root pain caused by prolapse of
the IVD. NP tissue was divided into two: one-half was fixed in
10% neutral buffered formalin and processed for histological
and immunohistochemical examination, and the remaining tis-
sue was used for RNA isolation. H&E-stained sections were
used to score the degree of morphological degeneration.
Briefly, tissue sections were scored for the presence of cell clus-
ters, the presence of fissures, loss of demarcation and loss of
hematoxophilia. A score of 0–4 indicates a histologically nor-
mal (non-degenerate) IVD, and a grade of 4.1–12 (4) indicates
evidence of degeneration. Gene-expression study samples were
classified as non-degenerate (4) and degenerate (4) based
on histological examination. Grading was performed indepen-
dently by two researchers, and grades were averaged.
Plasmids and reagents
Luciferase reporter plasmids were provided by the following:
TauT-luc, Ito et al. (26); WT CXCL1-luc, WT CXCL2-luc,
NF-B Mut CXCL1-luc, and NF-B Mut CXCL2-luc, Collier
and co-workers (28); Ton-TAD, pFR-luc, Burg and co-workers
(48); and NF-B-luc, Fu and Taubman (63). psPAX2 (12260),
pMD2G (12259), and FLAG-p65 (20012) (55) were from Add-
gene. As transfection control, pRL-TK (Promega) was used.
Lentiviral ShTonEBP (TRCN0000020019) and control ShRNA
pLKO.1 were from Sigma.
Lentiviral studies
HEK-293T cells in 10-cm plates (1.3 106 cells/plate) were
transfected with 9 g of either lentiviral ShCTR (pLKO.1) or
ShTonEBP plasmids, 6 g of psPAX2, 3 g of pMD2.G. After
16 h, the media were removed and replaced with DMEM with
5% FBS. Lentiviral particles were harvested at 48 and 60 h post-
transfection and concentrated using PEG solution. NP cells
were transduced with media containing viral particles and 8
g/ml Polybrene. Cells and conditioned medium were col-
lected 5 days post-transduction.
RNA sequencing
Illumina TruSeq-stranded total RNA sample preparation
with Ribo-Zero was used to prepare the library. Libraries were
chemically denatured and applied to an Illumina HiSeq version
4 single-read flow cell using an Illumina cBot. Hybridized mol-
ecules were clonally amplified and annealed to sequencing
primers with reagents from an Illumina HiSeq SR cluster kit
version 4-cBot. After transfer of the flow cell to an Illumina
HiSeq 2500, a 50-cycle single-read sequence runwas performed
(HiSeq SBS kit version 4). For data analysis, Rn5 Ensembl anno-
tations (Build 75) were downloaded and converted to genePred
format. Reads were aligned to the transcriptome reference
index using Novoalign (version 2.08.01), allowing up to 50
alignments for each read. Read counts were generated using
USeq’s DefinedRegionDifferentialSeq application and used in
DESeq2 to measure the differential expression between each
condition. Because of inherent variability between sets arising
from independent primary cell isolations, sample preparation
batch was accounted for during data normalization. Data have
been deposited to theGEODatabase (accession no.GSE97496).
For IPA, differentially expressed gene lists were used as input to
identify enriched related pathways, diseases, and networks.
Real-time qRT-PCR
For in vitro assays, total DNA-free RNA was extracted from
NP cells using RNeasy mini columns (Qiagen), and cDNA was
made using EcoDry premix (Clontech). For human tissue sam-
ples, extracted RNA was subjected to treatment with DNase
TNF--activated TonEBP regulates inflammatory genes
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(Qiagen, Crawley, UK) and purified using Qiagen MinElute
Cleanup kit prior to cDNA synthesis using Moloney murine
leukemia virus reverse transcriptase (Bioline, London, UK) and
random hexamers (Invitrogen). Gene expression of TonEBP
was determined in 42 IVD patient samples (2 post-mortem and
40 surgical) via real-time PCR analysis using predesigned,
6-carboxyfluorescein-labeledTaqManGeneExpressionAssays
(Applied Biosystems). 10 histologically non-degenerated sam-
ples (mean histological grade, 2.7 (range 1–4); mean age, 36
(range 20–45)) and 32 histologically degenerated samples
(mean histological grade, 8.2 (range 4.8–12); mean age, 40.9
(range 25–66)) were used for this component of the study.
Western blotting
Cells were placed on ice following treatment and washed
with ice-cold PBS. Buffers included 1 protease inhibitor mix-
ture (Roche Applied Science), NaF (4 mM), Na3VO4 (20 mM),
NaCl (150 mM), -glycerophosphate (50 mM), and DTT (0.2
mM). Nuclear proteins were isolated using the CellLytic
NuCLEAR extraction kit (Sigma). Proteins were resolved on 8%
SDS-polyacrylamide gels and transferred by electroblotting to
PVDF membranes (Bio-Rad). Membranes were blocked with
5% nonfat dry milk in TBST and incubated overnight at 4 °C in
blocking buffer with rabbit anti-TonEBP (1:1000, Abcam, cat-
alogue no. ab3446, lot GR303959-2), rabbit anti-lamin A/C
(1:1000, Cell Signaling, catalogue no. 2032), or mouse anti--
tubulin antibody (1:2000, DSHB, catalogue no. E-7). Specificity
of the TonEBP antibody has been demonstrated previously
(6). Immunolabeling was detected with ECL reagent. Chemilu-
minescence was detected using Digital Imaging System
ImageQuant LAS-400 (GEHealthcare). Densitometric analysis
was performed (ImageQuant) by first normalizing protein-of-
interest levels to the housekeeping protein (-tubulin) and then
normalizing to the experimental control group.
Immunohistochemical analysis
Expression of TonEBP was confirmed and localized via
immunohistochemistry in 30 IVDs (2 PM and 28 surgical sam-
ples) (supplemental Table 4). 10 histologically non-degenerate
samples (mean histological grade, 3.4 (range 2–4); mean age,
35.9 (range 21–46)) and 20 histologically degenerate samples
(mean histological grade, 7.7 (range 5–11); mean age, 44.1
(range 18–74)) were used. 4-m tissue sections were dewaxed
and rehydrated, and endogenous peroxidases were blocked.
Following heat antigen retrieval, sections were blocked in goat
serum and incubated overnight at 4 °C with rabbit polyclonal
antibody against human TonEBP (1:100; Abcam, catalogue no.
ab3446, lot GR223014-6). Rabbit polyclonal IgG (Abcam, cata-
logue no. ab27478, lot GR166285-4) was used as a negative con-
trol. After washing, sections were incubated with biotinylated
goat anti-rabbit antibody (1:500; Abcam, catalogue no.
ab97049, lot GR137025-3). Binding was detected using VEC-
TASTAIN Elite ABCHRP reagent (Vector Laboratories, Peter-
borough, UK) and 3,3-diaminobenzidine tetrahydrochloride
solution (Sigma). Sections were counterstained with Mayer’s
hematoxylin (Leica Microsystems, Milton Keynes, UK), dehy-
drated, cleared, and mounted in Pertex (Leica Microsystems).
Images were captured using an Olympus BX60 microscope,
QImaging Micropublisher 5.0 RTV camera, and QCapture Pro
version 8.0 software (Media Cybernetics, Marlow, UK) with
Olympic UPlan F1 40 or 100 objective. A total of 200 NP
cells were counted in each section and the number of immuno-
positive cells expressed as a percentage of total count.
Immunofluorescence
NP cells were plated on glass coverslips. After incubation
with various stimuli, cells were fixed and permeabilized with
ice-cold methanol for 15 min, blocked with PBS containing 5%
normal goat serum and 0.3% Triton X-100 for 1 h at room
temperature, and incubated with anti-TonEBP (1:150, Abcam)
at 4 °C overnight. Cells were washed and incubated with Alexa-
Fluor-594-conjugated anti-rabbit antibody (1:800, Jackson
ImmunoResearch). After washing, cells were mounted with
DAPI-containing mountant (Invitrogen) and visualized using a
fluorescence microscope (Zeiss Axio Imager A2 and imaged
with Axiocam mRm camera and Plan Apochromat 63
objective).
ELISA and dot blot
Conditioned medium was filtered (0.45 m) and supple-
mented with 1 protease inhibitor mixture (Roche Applied
Science). ELISAwas performedusingMini ELISAkits forCCL2
and IL-6 (PeproTech). CINC1/CXCL1, CINC3/CXCL2, and
CINC2/CXCL3 were detected using the RayBio Rat Cytokine
Antibody Array 2 (Ray Biotech Inc., Norcross, GA) following
the manufacturer’s instructions. Membranes were blocked,
incubated with conditioned medium, and incubated with bio-
tin-conjugated primary antibody mixture and then HRP-con-
jugated secondary antibody. Chemiluminescence was detected
using Digital Imaging System ImageQuant LAS-400 (GE
Healthcare).
Bioinformatic analysis of promoters and TonE prediction
Rat CXCL1 and CXCL2 promoter sequences were down-
loaded from the UCSC Genome Table Browser. MatInspector
(Genomatix) was used to identify predicted TonEBP-binding
sites (TonE), with score cutoff of 0.8. Ensembl browserwas used
for Multiz alignments of TonE predicted in the rat promoter
against human genome.
Transfections and Dual-LuciferaseTM assay
Cells were transferred to 48-well plates (2 104 cells/well) 1
day prior to transfection. To measure effects of stimuli on
TauT-luc activity, cells were transfected with 250 ng of TauT
promoter reporter and 250 ng of pRL-TK plasmid and cultured
in control, hypertonic, TNF-, IL-1, or LPS treatment condi-
tions. For gain- and loss-of-function studies, FLAG-TonEBP,
FLAG-DN-TonEBP, or backbone plasmid (150 ng) was co-
transfected with CXCL1, CXCL2, or NF-B reporter and
pRLTK. For experiments with p65 overexpression, 15 ng of
FLAG-p65 or backbonewas added alongwith reporter plasmid,
FLAG-TonEBP or FLAG-DN-TonEBP, and pRLTK. In all
experiments, plasmids were premixed with the transfection re-
agent, Lipofectamine 2000 (Invitrogen). 48 h after transfection,
cells were harvested, and firefly and Renilla luciferase activities
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were measured using the Dual-LuciferaseTM reporter assay
(Promega) and a luminometer (Tecan Infinite M200).
Site-directedmutagenesis
Site-directed mutagenesis of the rat CXCL1 promoter was
performed according to the manufacturer’s protocol, using the
Q5 site-directed mutagenesis kit (New England Biolabs). Prim-
ers used for CXCL1 promoter mutants are (mutated TonE
underlined): forward, 5-CCGGTTGTGGTTCCACACCCT-
GTG-3; reverse, 5-AAAGGACATCGCTCCTCC-3. Muta-
tions were verified by sequencing (Applied Biosystems 3730
DNA sequencer).
Statistics
For quantitative measurements, results are presented as the
mean S.E. Differences between groupswere assessed by anal-
ysis of variance and Student’s t test using GraphPad Prism soft-
ware. p values 0.05 were considered statistically significant.
Human expression data were non-parametric; thus, Kruskal-
Wallis test with post hoc analysis by Conover-Inman test was
used to determine significance between 2	CT values and per-
centage immunopositivity between groups. Spearman’s rank
correlation was used to determine correlations between gene
and expression for different targets.
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